ENSG
The Ensign Group, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$171.40
−0.40%Year over year
Reported trailing growth
- Revenue
- +18.9%
- EBITDA
- +18.2%
- EBIT
- +18.2%
- EPS
- +15.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +13.8%
- EBITDA
- +25.6%
- EPS
- +25.0%
Three-year CAGR
- Revenue
- +18.7%
- EBITDA
- +16.4%
- EBIT
- +12.7%
- Net income
- +15.3%
- EPS
- +13.6%
- Free cash flow
- +26.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026